Skip to main content
Published: 2020-02-10 12:51 | Updated: 2020-02-11 13:37

Current calls, week 7, 2020

Tips from Grants Office about current calls.

Swedish and Nordic calls

 

Public Health Agency of Sweden – Projektbidrag för suicidprevention

Dessa stöder ideellla organisationers framtagande och utvecklande av kunskap samt utbildning, informationsinsatser eller socialt stödjande arbete inom området. Den totala budgeten är värd SEK 20 miljoner och projekt kan pågå i upp till tre år.

Closing date: 24 February 2020

 

Public Health Agency of Sweden – Projektbidrag för suicidprevention

 

NordForsk – E-infrastructure collaboration, developement projects

This aims at developing services for a wide range of research problems within e-infrastructure of joint Nordic interest. Projects should a duration of up to three years.

Closing date: 26 February 2020

NordForsk – E-infrastructure collaboration, developement projects

 

Vetenskapsrådet - Swedish Research Council

 

Grant for half-time research position in a clinical environment

This enables clinically active persons to conduct research on a half-time basis in parallel with developing their clinical skills. Grants are worth up to SEK 1.85 million each per year for up to three years, with the possibility of a three-year extension. Maximum award: SEK 11,100,000

Closing date: 10 March 2020

Grant for half-time research position in a clinical environment 
 

Research project grant for development of methods to replace, reduce and refine animal experiments (3R)

These enables researchers to develop research ideas, methods and implementation on the principles of replace, reduce and refine animal experiments. Grants are worth between SEK 400,000 and SEK 800,000 for between one to three years. Maximum award: SEK 2,400,000

Closing date: 10 March 2020

Research project grant for development of methods to replace, reduce and refine animal experiments (3R) 
 

Research project grant within humanities and social sciences

This enables researchers to conduct a research project related to the humanities and social sciences. Grants are worth between SEK 400,000 and SEK 1.5 million per year each for between one and four years.  Maximum award: SEK 6,000,000

Closing date: 10 March 2020

Research project grant within humanities and social sciences 

 

Research project grant within medicine and health sciences

This enables researchers to conduct a research project related to medicine and health sciences. Grants are worth between SEK 400,000 and SEK 2.5 million per year each for a duration of one to five years. Maximum award: SEK 12,500,000

Closing date: 10 March 2020

Research project grant within medicine and health sciences

 

Starting grant within medicine and health

This enables junior researchers to establish themselves as independent researchers in Sweden. Grants are worth up to SEK 1.5 million each per year for up to four years.  Maximum award: SEK 6,000,000

Closing date: 10 March 2020

Starting grant within medicine and health

 

Research environment grant within humanities and social sciences

This aims to create added value in a research environment within the humanities and social sciences through collaboration in larger groupings and with a longer perspective than standard projects can offer. Grants are worth between SEK 1.5 million to SEK 3m per year for between four to six years. Maximum award: SEK 18,000,000

Closing date: 10 March 2020

Research environment grant within humanities and social sciences

 

Novo Nordisk Foundation – Exploratory pre-seed grants

These support application-oriented research and the testing of ideas that may lead to the development of new medical treatments, novel technologies, disease prevention, devices and diagnostic methods within the health sciences. Grants are worth up to DKK 500,000 over four to 12 months. Maximum award: DKK 500,000

Closing date: 1 April 2020

Novo Nordisk Foundation – Exploratory pre-seed grants

 

MAXIV -  workshop samt utlysning av tre projektbidrag

Missa inte detta tillfälle att ta del av presentationer av specialister från MAXIV samt forskare  som använt sig av MAXIV inom medicinsk forskning.

Vi utlyser också tre projektbidrag à 200 tkr för samarbete med MAXIV i samband med workshopen.

Först till kvarn! Anmäl er via länken.

För ytterligare frågor, kontakta vår vetenskapliga koordinator för SNIC och MAXIV, Martin Moche, Martin.Moche@ki.se.

European calls

 

H2020-FETOPEN-2018-2019-2020 novel ideas for radically new technologies, single stage

The European Commission Horizon 2020: Excellent Science, under the future and emerging technologies work programme, and the European Innovation Council invite proposals for their H2020-FETOPEN-2018-2019-2020 novel ideas for radically new technologies call. This supports projects that lay the foundations for radically new future technologies of any kind from visionary interdisciplinary collaborations that dissolve the traditional boundaries between sciences and disciplines, including the social sciences and humanities.

Proposals may take the form of research and innovation actions, which require participation by at least three legal entities; each established in a different EU member state or Horizon 2020 associated country. Each successful proposal is expected to receive up to €3 million, although proposals for other amounts will be considered. The total indicative budget is €637m.

Closing date: 13 May 2020

H2020-FETOPEN-2018-2019-2020 novel ideas for radically new technologies, single stage
 

Discovery research grant - Action on Hearing Loss, and other funders

Action on Hearing Loss invites applications for its discovery research grant. This supports projects that will generate knowledge to underpin the discovery of treatments for hearing loss or tinnitus, or improve how new treatments are developed and tested. This year, Action on Hearing Loss is working with Alzheimer’s Research UK to co-fund research that will increase understanding of the common biological mechanisms underlying hearing loss and dementia. Projects should focus on the following areas:

•understanding the links between dementia and hearing loss;

•research to underpin the development of treatments for hearing disorders, including tinnitus;

•research to improve how new treatments for hearing loss and tinnitus are developed and tested.

Applications in the area of tinnitus are encouraged. Applicants may be from any university or research institute based anywhere in the world. The funding is worth up to £200,000

Closing date: 14 February 2020

Discovery research grant - Action on Hearing Loss, and other funders

 

Young investigator programme - European Molecular Biology Organisation

The European Molecular Biology Organisation invites applications for its young investigator programme. This supports junior group leaders in the field of life sciences to set up their first independent laboratories.

Applications are accepted from candidates who:

  • have been an independent group leader for at least one year at the pre-application deadline and less than four years on 1 January in the year of application;
  • work in the life sciences in a European Molecular Biology Conference member state, associate member state or co-operating partner country;
  • have obtained sufficient funding to run their laboratory and have published at least one last author research paper in an international peer reviewed journal;
  • are 40 years old or younger on 1 January in the year of application, unless exceptional circumstances have significantly delayed career progression.

Awards are worth €15,000 each paid to investigators in their second year. Investigators may also apply for small grants of up to €10,000 per year

Closing date: 1 April 2020

Young investigator programme - European Molecular Biology Organisation 

 

EFSD/Sanofi European diabetes research programme in macrovascular complications

The European Foundation for the Study of Diabetes, in association with Sanofi, invites applications for its European diabetes research programme in macrovascular complications. This aims to advance current knowledge and to stimulate and accelerate European research on macrovascular complications. Grants support basic and clinical mechanistic studies. For basic mechanistic studies, innovative studies including use of advance stem cell approaches are particularly welcome. Studies involving classical animal models of macrovascular disease will not be considered.

Single non-profit institutions or groups of institutions from Europe and associated countries may apply. Grants are worth up to €250,000 each for a minimum of one year.

Closing date: 16 March 2020

EFSD/Sanofi European diabetes research programme in macrovascular complications

US calls

 

Next Generation Multipurpose Prevention Technologies (NGM) (R01 Clinical Trial Optional): NIH

The objective of this Funding Opportunity Announcement (FOA) is to support the development of new and innovative on-demand, event -driven and long-acting systemic and non-systemic multipurpose prevention technologies (MPT).  It supports development of MPTs that prevent HIV infection and pregnancy (hormonal and non-hormonal methods); sexually transmitted infections (STI) and pregnancy, and (HIV/STI) and non-HIV STI MPTs in cis and trans males and females of all ages. Applications for MPT development may involve pharmacokinetic (PK), pharmacodynamic (PD), safety and, drug-drug interactions (DDI) studies using drug development and formulation science supported by animal model testing. Also supported are biobehavioral and behavioral/social studies to identify MPT user-desired rheological and biophysical factors (look, feel, effectiveness, safety and duration of action) and other behavioral/social factors that could promote increased MPT adoption and use.

Deadlines: May 6, 2020; May 6, 2021, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.

Funding Opportunity Announcement (FOA): PAR-19-209

 

Women & Sex/Gender Differences in Drug and Alcohol Abuse/Dependence (R01, R21 Clinical Trial Optional, R03): NIH

The purpose of this FOA is two-fold: (1) to advance identification of male-female differences in drug and alcohol research outcomes, to uncover the mechanisms of those differences, and to conduct translational research on those differences, and (2) to advance research specific to women or highly relevant to women.  Both preclinical and clinical studies are sought across all areas of drug and alcohol research.

Deadlines: Standard dates, by 5:00 PM local time of applicant organization. 

Funding Opportunity Announcement (FOA): PA-18-603 (R01), PA-18-601 (R03), PA-18-602 (R21),

 

Epidemiology and Prevention in Alcohol Research (R01 - Clinical Trial Optional): NIH

This Funding Opportunity Announcement (FOA) encourages the submission of investigator-initiated research grant applications to support research investigating the epidemiology of alcohol use, alcohol-related harms, and alcohol use disorders and the prevention of underage drinking, alcohol-related harms, and alcohol use disorders.

Deadlines: Standard dates apply, by 5:00 PM local time of applicant organization. 

Funding Opportunity Announcement (FOA): PA-18-390 (R01), PA-18-413 (R03), PA-18-391 (R21)

 

Faculty grant programme, Marfan Foundation, US, US

The Marfan Foundation is requesting proposals to the Faculty Grant Program which supports two-year grants for basic, translation or clinical research. The grant program is designed to provide financial support for senior faculty members studying any or all disciplines involved in Marfan syndrome, EDS, LDS, and other related disorders. Grant awards are based on proposal evaluation by The Marfan Foundation Scientific Advisory Board with the approval of the Board of Director. The Marfan Foundation will award up to three 2-year $100,000 grants, no INDI coverage.
Special Areas Of Interest: Basic research, translational studies and clinical studies in cardiovascular, orthopedic, pulmonary, ophthalmologic, pain and other pertinent areas utilizing synergistic collaborations; integration of novel theories from non-traditional researchers into established paradigms; novel animal model systems; innovation; and the distillation of knowledge into practical new therapies, for Marfan syndrome, EDS, LDS, and other related disorders.

Eligibility: The principal investigator must hold an MD, DO, PhD, ScD, DDS, DVM or equivalent degree and must have proven ability to pursue independent research as evidenced by original research publications in peer-reviewed journals and should hold a position of associate professor or above.

Deadline: April 3, 2020

Faculty grant programme, Marfan Foundation, US (PDF)
 

Irvington postdoctoral fellowships, Cancer Research Institute, US

The CRI Irvington Postdoctoral Fellowship Program is CRI's longest-standing continuous program. Postdoctoral fellowships provide support to fund and train young immunologists and cancer immunologists at top universities and research centers around the world.

Fellows work and continue their training under the guidance of a world-renowned immunologist, who mentors the fellow and prepares him or her for a productive and successful career in cancer immunology.

Budget: Fellows receive up to $175,500 over three years to cover the cost of salary, insurance, and other research-related expenses, such as travel to conferences and meetings.

Eligibility:

  • Applicants for the CRI Irvington Postdoctoral Fellowship Program must be working in areas directly related to immunology or cancer immunology. An eligible project must fall into the broad field of immunology with relevance to solving the cancer problem.
  • Applicants must have a doctoral degree by the date of award activation and must conduct their proposed research under a sponsor who holds a formal appointment at the host institution.
  • Applicants with 5 or more years of relevant postdoctoral experience at the time of award activation are not eligible, with the exception of M.D. applicants, who should not include years of residency in this calculation.
  • Only in exceptional circumstances will applicants who have already spent 3 or more years in a sponsor’s laboratory by the start date of fellowship be considered for a fellowship award.

Deadline: April 1, 2020 Applications are due by 5 p.m. Eastern Time.

Irvington postdoctoral fellowships, Cancer Research Institute, US